Request for Covid-19 Impact Assessment of this Report
The United States Non Receptor Tyrosine Protein Kinase TYK2 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non Receptor Tyrosine Protein Kinase TYK2 market, reaching US$ million by the year 2028. As for the Europe Non Receptor Tyrosine Protein Kinase TYK2 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non Receptor Tyrosine Protein Kinase TYK2 players cover Array BioPharma Inc, Bristol-Myers Squibb Company, Nimbus Therapeutics LLC, and Pfizer Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non Receptor Tyrosine Protein Kinase TYK2 market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
ARRY-624
BMS-986165
Cerdulatinib
NDI-031232
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Follicular Lymphoma
Hypersensitivity
Lupus Nephritis
Marginal Zone B-cell Lymphoma
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Array BioPharma Inc
Bristol-Myers Squibb Company
Nimbus Therapeutics LLC
Pfizer Inc
Portola Pharmaceuticals Inc
Sareum Holdings Plc
Takeda Pharmaceutical Company Ltd
Theravance Biopharma Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non Receptor Tyrosine Protein Kinase TYK2 by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non Receptor Tyrosine Protein Kinase TYK2 by Country/Region, 2017, 2022 & 2028
2.2 Non Receptor Tyrosine Protein Kinase TYK2 Segment by Type
2.2.1 ARRY-624
2.2.2 BMS-986165
2.2.3 Cerdulatinib
2.2.4 NDI-031232
2.2.5 Others
2.3 Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
2.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
2.3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Type (2017-2022)
2.4 Non Receptor Tyrosine Protein Kinase TYK2 Segment by Application
2.4.1 Follicular Lymphoma
2.4.2 Hypersensitivity
2.4.3 Lupus Nephritis
2.4.4 Marginal Zone B-cell Lymphoma
2.4.5 Others
2.5 Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
2.5.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Market Share by Application (2017-2022)
2.5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Application (2017-2022)
3 Global Non Receptor Tyrosine Protein Kinase TYK2 by Company
3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Breakdown Data by Company
3.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales by Company (2020-2022)
3.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Company (2020-2022)
3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Revenue by Company (2020-2022)
3.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Company (2020-2022)
3.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Company (2020-2022)
3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Company
3.4 Key Manufacturers Non Receptor Tyrosine Protein Kinase TYK2 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non Receptor Tyrosine Protein Kinase TYK2 Product Location Distribution
3.4.2 Players Non Receptor Tyrosine Protein Kinase TYK2 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non Receptor Tyrosine Protein Kinase TYK2 by Geographic Region
4.1 World Historic Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Geographic Region (2017-2022)
4.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Revenue by Geographic Region
4.2 World Historic Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country/Region (2017-2022)
4.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Revenue by Country/Region
4.3 Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth
4.4 APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth
4.5 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth
4.6 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth
5 Americas
5.1 Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country
5.1.1 Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022)
5.1.2 Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022)
5.2 Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
5.3 Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region
6.1.1 APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2017-2022)
6.1.2 APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2017-2022)
6.2 APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
6.3 APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 by Country
7.1.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022)
7.1.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022)
7.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
7.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 by Country
8.1.1 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022)
8.2 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
8.3 Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non Receptor Tyrosine Protein Kinase TYK2
10.3 Manufacturing Process Analysis of Non Receptor Tyrosine Protein Kinase TYK2
10.4 Industry Chain Structure of Non Receptor Tyrosine Protein Kinase TYK2
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
11.3 Non Receptor Tyrosine Protein Kinase TYK2 Customer
12 World Forecast Review for Non Receptor Tyrosine Protein Kinase TYK2 by Geographic Region
12.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Forecast by Region
12.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Forecast by Region (2023-2028)
12.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non Receptor Tyrosine Protein Kinase TYK2 Forecast by Type
12.7 Global Non Receptor Tyrosine Protein Kinase TYK2 Forecast by Application
13 Key Players Analysis
13.1 Array BioPharma Inc
13.1.1 Array BioPharma Inc Company Information
13.1.2 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.1.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Array BioPharma Inc Main Business Overview
13.1.5 Array BioPharma Inc Latest Developments
13.2 Bristol-Myers Squibb Company
13.2.1 Bristol-Myers Squibb Company Company Information
13.2.2 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.2.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bristol-Myers Squibb Company Main Business Overview
13.2.5 Bristol-Myers Squibb Company Latest Developments
13.3 Nimbus Therapeutics LLC
13.3.1 Nimbus Therapeutics LLC Company Information
13.3.2 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.3.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Nimbus Therapeutics LLC Main Business Overview
13.3.5 Nimbus Therapeutics LLC Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.4.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Portola Pharmaceuticals Inc
13.5.1 Portola Pharmaceuticals Inc Company Information
13.5.2 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.5.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Portola Pharmaceuticals Inc Main Business Overview
13.5.5 Portola Pharmaceuticals Inc Latest Developments
13.6 Sareum Holdings Plc
13.6.1 Sareum Holdings Plc Company Information
13.6.2 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.6.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sareum Holdings Plc Main Business Overview
13.6.5 Sareum Holdings Plc Latest Developments
13.7 Takeda Pharmaceutical Company Ltd
13.7.1 Takeda Pharmaceutical Company Ltd Company Information
13.7.2 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.7.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Takeda Pharmaceutical Company Ltd Main Business Overview
13.7.5 Takeda Pharmaceutical Company Ltd Latest Developments
13.8 Theravance Biopharma Inc
13.8.1 Theravance Biopharma Inc Company Information
13.8.2 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
13.8.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Theravance Biopharma Inc Main Business Overview
13.8.5 Theravance Biopharma Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non Receptor Tyrosine Protein Kinase TYK2 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of ARRY-624
Table 4. Major Players of BMS-986165
Table 5. Major Players of Cerdulatinib
Table 6. Major Players of NDI-031232
Table 7. Major Players of Others
Table 8. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
Table 10. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2017-2022) & ($ million)
Table 11. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2017-2022)
Table 12. Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Table 15. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2017-2022)
Table 16. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2017-2022)
Table 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Company (2020-2022)
Table 20. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Company (2020-2022)
Table 22. Global Non Receptor Tyrosine Protein Kinase TYK2 Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Non Receptor Tyrosine Protein Kinase TYK2 Producing Area Distribution and Sales Area
Table 24. Players Non Receptor Tyrosine Protein Kinase TYK2 Products Offered
Table 25. Non Receptor Tyrosine Protein Kinase TYK2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share Geographic Region (2017-2022)
Table 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country/Region (2017-2022)
Table 34. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2017-2022)
Table 38. Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2017-2022)
Table 40. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
Table 42. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Table 44. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2017-2022)
Table 46. APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2017-2022)
Table 48. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
Table 50. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Table 52. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2017-2022)
Table 54. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2017-2022)
Table 56. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
Table 58. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Non Receptor Tyrosine Protein Kinase TYK2
Table 69. Key Market Challenges & Risks of Non Receptor Tyrosine Protein Kinase TYK2
Table 70. Key Industry Trends of Non Receptor Tyrosine Protein Kinase TYK2
Table 71. Non Receptor Tyrosine Protein Kinase TYK2 Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Non Receptor Tyrosine Protein Kinase TYK2 Distributors List
Table 74. Non Receptor Tyrosine Protein Kinase TYK2 Customer List
Table 75. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Forecast by Region
Table 77. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share Forecast by Application (2023-2028)
Table 95. Array BioPharma Inc Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 96. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 97. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Array BioPharma Inc Main Business
Table 99. Array BioPharma Inc Latest Developments
Table 100. Bristol-Myers Squibb Company Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 101. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 102. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Bristol-Myers Squibb Company Main Business
Table 104. Bristol-Myers Squibb Company Latest Developments
Table 105. Nimbus Therapeutics LLC Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 106. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 107. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Nimbus Therapeutics LLC Main Business
Table 109. Nimbus Therapeutics LLC Latest Developments
Table 110. Pfizer Inc Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 111. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 112. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Pfizer Inc Main Business
Table 114. Pfizer Inc Latest Developments
Table 115. Portola Pharmaceuticals Inc Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 116. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 117. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Portola Pharmaceuticals Inc Main Business
Table 119. Portola Pharmaceuticals Inc Latest Developments
Table 120. Sareum Holdings Plc Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 121. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 122. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Sareum Holdings Plc Main Business
Table 124. Sareum Holdings Plc Latest Developments
Table 125. Takeda Pharmaceutical Company Ltd Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 126. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 127. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Takeda Pharmaceutical Company Ltd Main Business
Table 129. Takeda Pharmaceutical Company Ltd Latest Developments
Table 130. Theravance Biopharma Inc Basic Information, Non Receptor Tyrosine Protein Kinase TYK2 Manufacturing Base, Sales Area and Its Competitors
Table 131. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Offered
Table 132. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Theravance Biopharma Inc Main Business
Table 134. Theravance Biopharma Inc Latest Developments
List of Figures
Figure 1. Picture of Non Receptor Tyrosine Protein Kinase TYK2
Figure 2. Non Receptor Tyrosine Protein Kinase TYK2 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of ARRY-624
Figure 10. Product Picture of BMS-986165
Figure 11. Product Picture of Cerdulatinib
Figure 12. Product Picture of NDI-031232
Figure 13. Product Picture of Others
Figure 14. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type in 2021
Figure 15. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2017-2022)
Figure 16. Non Receptor Tyrosine Protein Kinase TYK2 Consumed in Follicular Lymphoma
Figure 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Market: Follicular Lymphoma (2017-2022) & (K Pcs)
Figure 18. Non Receptor Tyrosine Protein Kinase TYK2 Consumed in Hypersensitivity
Figure 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Market: Hypersensitivity (2017-2022) & (K Pcs)
Figure 20. Non Receptor Tyrosine Protein Kinase TYK2 Consumed in Lupus Nephritis
Figure 21. Global Non Receptor Tyrosine Protein Kinase TYK2 Market: Lupus Nephritis (2017-2022) & (K Pcs)
Figure 22. Non Receptor Tyrosine Protein Kinase TYK2 Consumed in Marginal Zone B-cell Lymphoma
Figure 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Market: Marginal Zone B-cell Lymphoma (2017-2022) & (K Pcs)
Figure 24. Non Receptor Tyrosine Protein Kinase TYK2 Consumed in Others
Figure 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2017-2022)
Figure 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application in 2021
Figure 28. Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Company in 2021
Figure 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Geographic Region in 2021
Figure 32. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2017-2022)
Figure 33. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country/Region in 2021
Figure 34. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales 2017-2022 (K Pcs)
Figure 35. Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue 2017-2022 ($ Millions)
Figure 36. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales 2017-2022 (K Pcs)
Figure 37. APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue 2017-2022 ($ Millions)
Figure 38. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales 2017-2022 (K Pcs)
Figure 39. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue 2017-2022 ($ Millions)
Figure 42. Americas Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country in 2021
Figure 43. Americas Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country in 2021
Figure 44. United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region in 2021
Figure 49. APAC Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Regions in 2021
Figure 50. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country in 2021
Figure 57. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country in 2021
Figure 58. Germany Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Country in 2021
Figure 65. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Non Receptor Tyrosine Protein Kinase TYK2 Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Non Receptor Tyrosine Protein Kinase TYK2 in 2021
Figure 71. Manufacturing Process Analysis of Non Receptor Tyrosine Protein Kinase TYK2
Figure 72. Industry Chain Structure of Non Receptor Tyrosine Protein Kinase TYK2
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...